ROLE OF CONNECTIVE-TISSUE AUTOIMMUNITY IN GRAVES OPHTHALMOPATHY

被引:23
作者
BAHN, RS
HEUFELDER, AE
机构
[1] Department of Internal Medicine, Division of Endocrinology, Mayo Clinic/Foundation, Rochester, MN
关键词
GRAVES OPHTHALMOPATHY; FIBROBLASTS; CONNECTIVE TISSUE AUTOIMMUNITY;
D O I
10.3109/08916939209014638
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Histologic similarities exist between the tissues involved in the extrathyroidal manifestations of Graves' disease, namely ophthalmopathy and pretibial dermopathy. Both conditions are characterized by an accumulation of glycosaminoglycans (GAGs) and an infiltration of lymphocytes. We have shown that interleukin-1 and transforming growth factor-beta, cytokines released by the local inflammatory cell infiltrate, are capable of stimulating GAG synthesis by retroocular and pretibial fibroblasts. Additionally, affected retroocular and pretibial fibroblasts demonstrate an enhanced induction of HLA-DR in response to interferon-gamma treatment and both cell types express the 72 kDa heat shock protein in vivo and in vitro. Retroocular and pretibial fibroblasts from patients with Graves' ophthalmopathy and pretibial dermopathy thus seem to possess unique immunological features that may render them more susceptible to the autoimmune process in Graves' disease. Chronic stimulation of fibroblasts by cytokines released in the local inflammatory milieu may result in excessive GAG production. The accumulation of these hydrophilic mucopolysaccharides, with its associated edema, leads to the clinical manifestations of Graves' ophthalmopathy and pretibial dermopathy.
引用
收藏
页码:75 / 79
页数:5
相关论文
共 43 条
[21]  
Hanafusa T., Pujol-Borrel R., Chiovato L., Aberrant expression of HLA-DR antigen on thyrocytes of Graves' disease: relevance to thyroid autoimmunity, Lancet, 2, (1983)
[22]  
David T.F., Piccinini L.A., Intrathyroidal MHC class II antigen expression and thyroid autoimmunity, Endocrinol Metab Clin North Am, 16, (1987)
[23]  
Reich E.P., Sherwin R.S., Kanagawa O., Janeway C., An explanation for the protective effect of MHC class I-E molecule in murine diabetes, Nature, 341, pp. 326-328, (1989)
[24]  
Iwatani Y., Gerstein H., Iitaka M., Row V., Volpe R., Thyrocyte HLA-DR expression and interferon-gamma production in autoimmune thyroid disease, J Clin Endocrinol Metab, 63, pp. 695-708, (1986)
[25]  
Weetman A., Volkman D., Burman K., Gerrard T., Faudi A., The in vitro regulation of human thyrocytes HLA-DR antigen expression, J Clin Endocrinol Metab, 61, pp. 817-824, (1985)
[26]  
Heufelder A.E., Smith T.J., Gorman C.A., Bahn R.S., Increased induction of HLA-DR by interferon-gamma in cultured fibroblasts derived from patients with Graves' ophthalmopathy and pretibial dermopathy, J Clin Endocrinol Metab, 73, pp. 307-313, (1991)
[27]  
Lindquist S., The heat-shock response, Ann Rev Biochem, 55, pp. 1151-1191, (1986)
[28]  
Chiang H.-L., Terlecky S.R., Plant C.L.P., Dice J.F., A role for a 70-kilodalton heat shock protein in lysosomal degradation of intracellular proteins, Science, 246, pp. 382-385, (1989)
[29]  
Pechan P.M., Heat shock proteins and cell proliferation, FEBS Le, 280, pp. 1-4, (1991)
[30]  
Kaufmann S.H.E., Heat shock proteins and the immune response, Immunol Today, 11, pp. 129-136, (1990)